REDWOOD CITY, CA, USA I June 11, 2025 I Juvena Therapeutics, Inc. (“Juvena”), a clinical-stage biotechnology company pioneering tissue restorative biologics ...

LONDON, UK I June 13, 2025 I GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted the company’s regulatory ...

LONDON, UK I June 12, 2025 I GSK plc (LSE/NYSE: GSK) announced today that it has licensed its Shigella vaccine candidate, altSonflex1-2-3, to Bharat Biotech ...

STOCKHOLM, Sweden I June 13, 2025 I BioArctic AB (publ) (NASDAQ Stockholm: BIOA B) announced today that the interim safety review of the clinical Phase 2a ...

TAINAN, Taiwan I June 12, 2025 I Merry Life Biomedical Company announces the launch of its global Phase II clinical trial for TML-6, a novel oral small ...

BAGSVAERD, Denmark I June 12, 2025 I Novo Nordisk today announced that it will advance subcutaneous and oral amycretin into phase 3 development in weight ...

HAMPTON, NJ, USA I June 12, 2025 I Celldex (NASDAQ:CLDX) announced today new data demonstrating profound, sustained complete response and improved quality of ...

Company to discuss glycan-targeting ADC platform during BIO International Convention 2025. NEW TAIPEI CITY, Taiwan I June 12, 2025 I GlycoNex, Inc. (4168, hereinafter referred to ...

Research program combining Debiopharm’s AbYlink™ conjugation technology with Alkyon’s modular antibody platform and novel targeting approaches is set to drive ...

MOBILIZE-1 is the first Phase 3 study being initiated for V181 as part of a planned robust clinical development program ...

BOSTON, MA, USA I June 12, 2025 I EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, a leading science and ...

Breakthrough in AI-powered drug discovery validates HYFT™-driven peptide design, with broad potential across multiple therapeutic areas ...